Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 414 Carcinoma, Non-Small-Cell Lung 287 Prostatic Neoplasms 208 Neoplasms 204 Neoplasm Metastasis 181 Melanoma 164 Colorectal Neoplasms 159 Multiple Myeloma 158 Leukemia, Myeloid, Acute 143 Lung Neoplasms 132 Leukemia 126 Lymphoma 118 Pancreatic Neoplasms 117 Recurrence 111 Ovarian Neoplasms 111 Leukemia, Lymphocytic, Chronic, B-Cell 110 Lymphoma, Non-Hodgkin 105 Carcinoma, Renal Cell 104 Brain Neoplasms 90 Myelodysplastic Syndromes 88 Precursor Cell Lymphoblastic Leukemia-Lymphoma 86 Glioblastoma 85 Lymphoma, Large B-Cell, Diffuse 80 Lymphoma, Follicular 79 Carcinoma, Hepatocellular 79 Head and Neck Neoplasms 77 Squamous Cell Carcinoma of Head and Neck 76 Urinary Bladder Neoplasms 66 Stomach Neoplasms 61 Hodgkin Disease 60

Interventions

Dehydroepiandrosterone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × Metastatic Breastcancer × Clear all

NCT02000375 2016-09-29

ARTT

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Terminated

Metastatic Breastcancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡